Sign In
Free Newsletter
New Jersey builds on legacy of leadership in life sciences
New Jersey's life sciences industry tops 127,000 workers as a new report highlights biotech growth, manufacturing and innovation.
Report: NJ expands life sciences leadership
New Jersey expands its life sciences leadership with biotech growth, new biomanufacturing space and innovation investments.
OPINION: How New Jersey is leading AI innovation in life sciences
The Garden State is emerging as a national pioneer in artificial intelligence-driven advances in the field, transforming health care, drug discovery and biomanufacturing.
NEST campus in Kenilworth begins multimillion-dollar renovation (photos)
Ownership will add 75,000 square feet of modernized amenity space at the sprawling life sciences and technology campus that previously served as Merck's headquarters.
Middlesex College opens aseptic lab with J&J support
With support from Johnson & Johnson and other industry partners, the simulation space trains students for biotech and biomanufacturing careers through NJBioFutures.
MCCC launches aseptic biomanufacturing program, mobile lab
Mercer County Community College's new offering aims to train students for careers in biotechnology and cell therapy.
ProBio opens cell, gene therapy hub in Hopewell
Located at the Princeton West Innovation Campus, the new 128,000-square-foot facility will create more than 110 high-skilled jobs.
Cellares, Bristol Myers Squibb expand manufacturing agreement
The announcement comes weeks after BMS first entered the Cellares Technology Adoption Partnership (TAP) program — a fast and low-risk opportunity for cell therapy developers to use the automated technology for products in their pipeline.
Cellares raises $255M for Bridgewater cell therapy development facility
The funding will help launch the world's first Integrated Development and Manufacturing Organization (IDMO) Smart Factory, marking "the beginning of a new era, in which cell therapies will finally be able to reach patients in need,” according to company CEO Fabian Gerlinghaus.
Rutgers Cancer Institute treats 1st patient using genetically modified T-cells
Through the center's specialized facility and research, "we have the potential to transform the lives of patients with cancer,” said Dr. Christian Hinrichs, chief of cancer immunotherapy.
Enzene Biosciences bringing biomanufacturing facility, 300 jobs to Hopewell
“Yet another Indian biopharma company has established itself in the state, demonstrating the strength of the New Jersey-India economic partnership,” said Wesley Mathews, president and CEO of Choose New Jersey.
BioNJ holds in-person Manufacturing Brief at NJIT
The event marked the first in-person biomanufacturing conference from the organization in two years. "[W]e want to make sure that we’re supporting New Jersey’s life sciences ecosystem and make sure that it is a place where innovation is happening unencumbered and then patients can access that innovation," said President and CEO Debbie Hart.
